957372-81-5Relevant articles and documents
C-GLYCOLIPIDS WITH ENHANCED TH-1 PROFILE
-
Page/Page column 36, (2008/06/13)
The invention is directed to novel synthetic C-glycolipids that selectively induce a ThI -type immune response characterized by enhanced IL- 12 secretion and increased activation of dendritic cells. The compounds of the invention are thereby useful in treating infections, cancers, cell proliferative disorders, and autoimmune diseases, both directly and as adjuvants.